1. Home
  2. ACOG vs BZFD Comparison

ACOG vs BZFD Comparison

Compare ACOG & BZFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • BZFD
  • Stock Information
  • Founded
  • ACOG 2000
  • BZFD 2006
  • Country
  • ACOG Canada
  • BZFD United States
  • Employees
  • ACOG N/A
  • BZFD N/A
  • Industry
  • ACOG
  • BZFD Movies/Entertainment
  • Sector
  • ACOG
  • BZFD Consumer Discretionary
  • Exchange
  • ACOG Nasdaq
  • BZFD Nasdaq
  • Market Cap
  • ACOG 80.3M
  • BZFD 82.8M
  • IPO Year
  • ACOG N/A
  • BZFD N/A
  • Fundamental
  • Price
  • ACOG $9.16
  • BZFD $2.05
  • Analyst Decision
  • ACOG Strong Buy
  • BZFD
  • Analyst Count
  • ACOG 1
  • BZFD 0
  • Target Price
  • ACOG $20.00
  • BZFD N/A
  • AVG Volume (30 Days)
  • ACOG 130.0K
  • BZFD 318.1K
  • Earning Date
  • ACOG 08-14-2025
  • BZFD 08-11-2025
  • Dividend Yield
  • ACOG N/A
  • BZFD N/A
  • EPS Growth
  • ACOG N/A
  • BZFD N/A
  • EPS
  • ACOG N/A
  • BZFD 0.34
  • Revenue
  • ACOG $2,928,654.00
  • BZFD $188,899,000.00
  • Revenue This Year
  • ACOG N/A
  • BZFD $6.29
  • Revenue Next Year
  • ACOG N/A
  • BZFD $6.16
  • P/E Ratio
  • ACOG N/A
  • BZFD $6.12
  • Revenue Growth
  • ACOG N/A
  • BZFD N/A
  • 52 Week Low
  • ACOG $3.75
  • BZFD $1.61
  • 52 Week High
  • ACOG $11.40
  • BZFD $5.68
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • BZFD 48.13
  • Support Level
  • ACOG N/A
  • BZFD $2.05
  • Resistance Level
  • ACOG N/A
  • BZFD $2.35
  • Average True Range (ATR)
  • ACOG 0.00
  • BZFD 0.10
  • MACD
  • ACOG 0.00
  • BZFD -0.02
  • Stochastic Oscillator
  • ACOG 0.00
  • BZFD 3.33

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About BZFD BuzzFeed Inc.

BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.

Share on Social Networks: